01.12.21

Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX for the Treatment of Wet AMD

Source: Clearside Biomedical

08.26.20

Clearside Biomedical Expands Patent Portfolio in the US and Europe

Source: Clearside Biomedical

08.10.20

Clearside Biomedical Announces FDA Acceptance of Investigational NDA for CLS-AX Administered in Suprachoroidal Space

Source: Clearside Biomedical

View more stories